Pharma consolidation continues with two new massive deals

 
Billy Bambrough
Follow Billy
Britain Sees Rise In Demand For Legal Highs
In March it was revealed that Medivation had hired bankers to defend itself against a potential takeover bid (Source: Getty)

The latest round of consolidation in the pharmaceutical industry has seen a combined £24bn worth of potential deals.

French phara giant Sanofi yesterday made a play for cancer therapy drug specialist Medivation with an unsolicited bid worth $9.3bn (£6.4bn).

Sanofi has sent a letter to the head of Medivation offering to buy the company after Medivation chief executive David Hung, told Sanofi earlier this month that his company was not interested in a deal.

Meanwhile, US drug maker Abbott Laboratories is looking to pump up its cardiovascular device business after agreeing to buy St Jude Medical for $25bn.

Abbott will take on £3.9bn of St Jude’s debt though it predicts savings of around £340m over the next four years.

Related articles